findmyKOL

Rupesh Raina, MD

Basic profile

Cleveland Clinic

ORCID↗NPI↗
✓ Full record
RegionAkron, OH · MidwestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL type: NationalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Rupesh Raina is a Nephrology physician affiliated with Cleveland Clinic. OpenAlex indexes 472 publications with 8,721 citations (h-index 47).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
472publications

Distinct works indexed by OpenAlex, matched via ORCID.

8,721citations

Total citations across indexed works.

47h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
14companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

224 W Exchange St
Akron, OH 443021704

Telephone

330-436-3150

Provider last certified this registry record 29 Apr 2026.

View the NPPES registry record

Industry payments

14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    54.6%
    Loop diuretic21%
    Furosemide40%Torsemide30%Bumetanide30%
    Part D<11 patients
    Beta blocker10.6%
    Metoprolol Tartrate29%Carvedilol24%Propranolol Hcl24%Labetalol Hcl23%
    Part D<11 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    19.7%
    SGLT2 inhibitor9.4%
    Farxiga100%
    Part D≥11 patients
    Potassium supplement4.1%
    Potassium Chloride100%
    Part D<11 patients

    + 2 more classes in this area

  • Other

    10.1%
    Phosphate Binder6.4%
    Sevelamer Carbonate100%
    Part D≥18 patients
    Drugs for treatment of hyperkalemia and hyperphosphatemia3.8%
    Velphoro100%
    Part D<11 patients
Where care is delivered (Part B)83.5% facility · 16.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”